tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Financial Statements

215 Followers

Elevation Oncology Financial Overview

Elevation Oncology's market cap is currently ―. The company's EPS TTM is $-1.029; its P/E ratio is -2.56; Elevation Oncology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.87M$ -7.95M$ -10.63M$ -10.11M$ -17.05M
EBITDA$ -9.86M$ -7.94M$ -10.82M$ -10.12M$ -17.20M
Net Income Common Stockholders$ -10.71M$ -7.90M$ -10.64M$ -10.11M$ -17.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 104.05M$ 83.11M$ 94.80M$ 107.92M$ 73.93M
Total Assets$ 108.96M$ 89.09M$ 99.97M$ 110.37M$ 76.90M
Total Debt$ 30.81M$ 30.14M$ 29.95M$ 29.77M$ 29.60M
Net Debt$ -73.24M$ -52.97M$ -64.84M$ -78.15M$ -44.33M
Total Liabilities$ 33.14M$ 34.28M$ 37.56M$ 38.19M$ 43.13M
Stockholders Equity$ 75.82M$ 54.81M$ 62.42M$ 72.17M$ 33.79M
Cash Flow-
Free Cash Flow$ -9.57M$ -12.18M$ -13.36M$ -13.81M$ -16.83M
Operating Cash Flow$ -9.57M$ -12.18M$ -13.36M$ -13.81M$ -16.83M
Investing Cash Flow$ 20.70M$ 6.56M$ -38.12M$ 16.50M$ 26.60M
Financing Cash Flow$ 30.25M$ -2.00K$ 27.00K$ 47.73M$ 216.00K
Currency in USD

Elevation Oncology Earnings and Revenue History

Elevation Oncology Debt to Assets

Elevation Oncology Cash Flow

Elevation Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis